Kinsale Capital Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.93M | Buy |
149,777
+17,687
| +13% | +$819K | 1.42% | 30 |
|
|
2025
Q1 | $8.06M | Buy |
132,090
+20,820
| +19% | +$1.27M | 1.98% | 23 |
|
|
2024
Q4 | $6.29M | Buy |
111,270
+15,673
| +16% | +$886K | 1.69% | 24 |
|
|
2024
Q3 | $4.95M | Buy |
95,597
+18,163
| +23% | +$940K | 1.46% | 30 |
|
|
2024
Q2 | $3.22M | Buy |
77,434
+18,498
| +31% | +$768K | 1.11% | 34 |
|
|
2024
Q1 | $3.2M | Buy |
58,936
+15,987
| +37% | +$867K | 1.26% | 33 |
|
|
2023
Q4 | $2.2M | Buy |
42,949
+14,537
| +51% | +$746K | 1.09% | 31 |
|
|
2023
Q3 | $1.65M | Buy |
28,412
+9,521
| +50% | +$553K | 0.94% | 30 |
|
|
2023
Q2 | $1.21M | Buy |
18,891
+7,697
| +69% | +$492K | 0.73% | 33 |
|
|
2023
Q1 | $776K | Buy |
+11,194
| New | +$776K | 0.57% | 26 |
|